Study of Genetic Factors Affecting Severity in 22q11.2 Deletion Syndrome

What this Trial Is About

22q11.2 deletion syndrome is a genetic disorder caused by the loss of a small part of chromosome 22, affecting many parts of the body and leading to conditions such as heart defects, immune deficiencies, kidney issues, hearing loss, facial deformities, developmental delays, learning disabilities, and increased risk of mental illnesses like schizophrenia, depression, anxiety, and bipolar disorder. Severity varies widely, with some people showing many symptoms and others very few, sometimes without even knowing they have the syndrome. This research aims to identify genetic variations that influence the severity of 22q11.2 deletion syndrome by analyzing DNA from affected individuals. Participants in this observational study will provide genetic material collected from blood or saliva during one study visit. The study will analyze the DNA sequences to find genetic differences that might explain the varying severity of the disorder. This single-visit approach allows researchers to gather important genetic information without requiring ongoing treatment or intervention. During the single study visit, participants will provide a blood or saliva sample for DNA analysis. The study will focus on collecting and examining genetic data to understand how different genetic factors may impact the disorders severity. There are no treatments or medications involved, and participants will not have additional visits related to this study. The total involvement requires only one visit for sample collection and data gathering.

Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome